Oruka Therapeutics (ORKA) EPS (Basic) Growth (5y) (2015 - 2024)
Oruka Therapeutics (ORKA) EPS (Basic) Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1.86% |
| Mar 31, 2024 | 23.60% |
| Dec 31, 2023 | 47.48% |
| Sep 30, 2023 | 43.14% |
| Jun 30, 2023 | 47.82% |
| Mar 31, 2023 | 51.63% |
| Dec 31, 2022 | 59.36% |
| Sep 30, 2022 | 52.59% |
| Jun 30, 2022 | 52.79% |
| Mar 31, 2022 | 51.73% |
| Dec 31, 2021 | 45.48% |
| Sep 30, 2021 | 48.93% |
| Jun 30, 2021 | 46.85% |
| Mar 31, 2021 | 46.27% |
| Dec 31, 2020 | 34.26% |
| Sep 30, 2020 | 43.27% |
| Jun 30, 2020 | 43.30% |
| Mar 31, 2020 | 44.92% |
| Dec 31, 2019 | 43.45% |
| Sep 30, 2019 | 43.91% |